CHRONIC LYMPHOCYTIC LEUKEMIA MRD BY FLOW CYTOMETER / EDTA BLOOD

image not found

NABL Cap Accredited 
The Chronic Lymphocytic Leukemia MRD by Flow Cytometer / EDTA Blood test measures minimal residual disease (MRD) in patients with CLL to detect low levels of leukemic cells after treatment. Metropolis Healthcare uses advanced flow cytometry techniques with highly sensitive antibody panels to provide precise quantification. This test helps clinicians monitor treatment response, assess remission status, and guide further therapeutic decisions. An EDTA blood sample ensures accurate evaluation of lymphocyte populations.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 14,000.00

Sample Type: EDTA BLOOD

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You can make the payment to the technician at the time of collection
  4. Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
  5. Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.

Frequently Asked Questions (FAQ's):

What does the CLL MRD by Flow Cytometer test include?
This test detects and quantifies minimal residual leukemic cells in blood to monitor disease status and treatment effectiveness.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses multi-color flow cytometry with validated protocols and antibody panels to accurately identify residual CLL cells in EDTA blood.

Who should take this test?
Patients diagnosed with chronic lymphocytic leukemia undergoing therapy or in remission may be advised to monitor MRD for treatment evaluation.

What sample type is required?
An EDTA anticoagulated blood sample is needed to maintain viable lymphocytes for precise flow cytometric analysis.

Why is MRD monitoring important in CLL?
Measuring minimal residual disease helps determine treatment response, predict relapse risk, and guide ongoing therapeutic decisions.

How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows strict quality control, validated flow cytometry protocols, and expert interpretation to ensure accurate and reproducible results.

Is any preparation needed before the test?
No special preparation is required; patients should provide the sample according to physician instructions.

How soon are results available?
Turnaround time may vary, but Metropolis Healthcare typically provides timely reports to support clinical decision-making and follow-up care.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab